BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3180784)

  • 21. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis.
    Isaksson M; Brandão FM; Bruze M; Goossens A
    Contact Dermatitis; 2000 Jul; 43(1):41-2. PubMed ID: 10902588
    [No Abstract]   [Full Text] [Related]  

  • 23. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergy to 2 new corticoid molecules.
    Boujnah-Khouadja A; Brändle I; Reuter G; Foussereau J
    Contact Dermatitis; 1984 Aug; 11(2):83-7. PubMed ID: 6488784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group.
    Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R
    Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of contact allergy to corticosteroids in a Danish patient population.
    Svendsen SV; Bach RO; Mortz CG
    Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of tixocortol-pivalate-positive patch tests in leg ulcer patients.
    Wilkinson M; Cartwright P; English JS
    Contact Dermatitis; 1990 Aug; 23(2):120-1. PubMed ID: 2145125
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic contact dermatitis caused by systemic corticosteroid use.
    Murata Y; Kumano K; Ueda T; Araki N; Nakamura T; Tani M
    Arch Dermatol; 1997 Aug; 133(8):1053-4. PubMed ID: 9267261
    [No Abstract]   [Full Text] [Related]  

  • 34. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact allergy to hydrocortisone.
    Lindelöf B
    Contact Dermatitis; 1988 May; 18(5):309. PubMed ID: 3416596
    [No Abstract]   [Full Text] [Related]  

  • 36. The benefit of patch testing with a corticosteroid at a low concentration.
    Isaksson M; Bruze M; Björkner B; Hindsén M; Svensson L
    Am J Contact Dermat; 1999 Mar; 10(1):31-3. PubMed ID: 10072336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sensitizing capacity of tixocortol pivalate.
    Hausen BM; Foussereau J
    Contact Dermatitis; 1988 Jan; 18(1):63-4. PubMed ID: 3349788
    [No Abstract]   [Full Text] [Related]  

  • 38. [An unrecognized cause of allergic eczema of the face: a corticoid, tixocortol pivalate].
    Foussereau J; Jelen G
    Presse Med; 1987 May; 16(17):832. PubMed ID: 2954110
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydrocortisone sensitivity. An investigation into the nature of the allergen.
    Wilkinson SM; English JS
    Contact Dermatitis; 1991 Sep; 25(3):178-81. PubMed ID: 1838313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact allergy to corticosteroids in asthma/rhinitis patients.
    Isaksson M; Bruze M; Hörnblad Y; Svenonius E; Wihl JA
    Contact Dermatitis; 1999 Jun; 40(6):327-8. PubMed ID: 10385338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.